LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). WHEN THE REFERENCE VALUES OF APOLIPOPROTEINS A AND B HAVE TO BE REVIEWED… [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine. |
LUTTERI, L., CARLISI, I., STOJKOVIC, V., & CAVALIER, E. (15 November 2019). Evaluation of inflammatory proteins tests using Optilite Analyzer [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine. |
  | Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566  Peer Reviewed verified by ORBi |
  | CAVALIER, E., CARLISI, I., KOVACS, S., WATAR, F., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (April 2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Osteoporosis International, 27 (Supplement 1), 512. Peer Reviewed verified by ORBi |
 | ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., LUKAS, P., CARLISI, I., LE GOFF, C., GADISSEUR, R., & CAVALIER, E. (August 2015). Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects. Burns: Journal of the International Society for Burn Injuries, 41 (5), 1028-1034. doi:10.1016/j.burns.2014.11.011 Peer Reviewed verified by ORBi |
 | CAVALIER, E., GADISSEUR, R., GEBOES, S., BEKAERT, A.-C., CARLISI, I., Bruyère, O., & Reginster, J.-Y. (2015). Critical evaluation of promising markers for sarcopenia. Osteoporosis International, 26 (S1), 49-S50. Peer Reviewed verified by ORBi |
 | CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027 Peer Reviewed verified by ORBi |
 | CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (20 April 2014). Evaluation of automated immunoassays for 25 (OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clinica Chimica Acta, 431, 60-5. doi:10.1016/j.cca.2014.01.026 Peer Reviewed verified by ORBi |
 | CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays [Poster presentation]. WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain. |
 | ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., CARLISI, I., LUKAS, P., GADISSEUR, R., & CAVALIER, E. (2014). Vitamin D status during acute phase of burn injury : is 25(OH)D measurement an accurate marker ? Nutrients, 6, 2770. Peer Reviewed verified by ORBi |
 | CAVALIER, E., ROUSSELLE, O., FERRANTE, N., CARLISI, I., LE GOFF, C., & Souberbielle, J.-C. (October 2013). Technical and clinical evaluation of the VITROS Immunodiagnostic Products 25-OH Vitamin D Total Assay - comparison with marketed automated immunoassays and a liquid chromatography - tandem mass spectrometry method. Clinical Chemistry and Laboratory Medicine, 51 (10), 1983-1989. doi:10.1515/cclm-2013-0138 Peer Reviewed verified by ORBi |
 | Morovat, A., Catchpole, A., MEURISSE, A., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., paddon, M., James, T., & CAVALIER, E. (October 2013). IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clinical Chemistry and Laboratory Medicine, 51 (10), 2009-2018. doi:10.1515/cclm-2012-0531 Peer Reviewed verified by ORBi |
 | CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118. Peer Reviewed verified by ORBi |
 | GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay [Poster presentation]. AACC Annual meeting 2013, Houston, United States. |
 | CAVALIER, E., LUKAS, P., CARLISI, I., & Souberbielle, J.-C. (July 2013). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the restandarization of six different 25 (OH) vitamin D immunoassays [Poster presentation]. AACC Annual meeting 2013, Houston, United States. |
 | GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Performance of the IDS-iSYS 1,25-dihydroxy vitamin D assay [Poster presentation]. AACC Annual meeting, Houston, United States. |
 | CAVALIER, E., LE GOFF, C., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., DELANAYE, P., & Souberbielle, J.-C. (May 2013). Comparison of the total error obtained with six immuno-assays for 25-hydroxy vitamin D with the minimal, desirable and optimal total allowable errors calculated according to the biological variation. Biochimica Clinica, 37 (SS), 259. Peer reviewed |
 | Schleck, M.-L., LAURENT, T., GADISSEUR, R., CARLISI, I., ROUSSELLE, O., & CAVALIER, E. (May 2013). Evaluation of the third-generation to second-generation PTH ratio on the Liaison XL (DIASORIN) as a marker for parathyroïd carcinoma. Biochimica Clinica, 37 (SS), 161. Peer reviewed |
 | GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (May 2013). Evaluation of the performance of the new automated IDS-ISYS 1,25-dihydroxy vitamin D assay. Biochimica Clinica, 37 (SS), 498. Peer reviewed |
 | CAVALIER, E., GADISSEUR, R., LUKAS, P., CARLISI, I., & DELANAYE, P. (May 2013). Association of the circulating inactive form of matrix GLA protein (DP-UCMGP) levels and abdominal aortic calcification score (AACS) in haemodialysis patients. Biochimica Clinica, 37 (SS), 215. Peer reviewed |
 | CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498. Peer reviewed |
 | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282. Peer Reviewed verified by ORBi |
 | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329. Peer Reviewed verified by ORBi |
 | LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279. Peer Reviewed verified by ORBi |
 | CAVALIER, E., DELANAYE, P., CARLISI, I., BEKAERT, A.-C., FERRANTE, N., ROUSSELLE, O., & MORANNE, O. (17 July 2012). Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two Measurements [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., ROUSSELLE, O., & DELANAYE, P. (17 July 2012). Comparison of two automated 3rd generation PTH assays in different clinical populations [Poster presentation]. AACC 2012, Los Angeles, United States. |
 | CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., Koivula, M.-K., & Risteli, J. (May 2012). Observed Ranges for the Healthy Paediatrics in the Serum IDS-ISYS CrossLaps® (SCTX-I) [Poster presentation]. European Calcified Tissue Society 39th Annual Congress, Stockholm, Sweden. |
 | CAVALIER, E., CARLISI, I., ROUSSELLE, O., FERRANTE, N., & DELANAYE, P. (March 2012). Difference between total and intact assays for N-terminal propeptide of type I procollagen in renal impaired patients. Osteoporosis International, 23 (Supplement 2), 339. Peer Reviewed verified by ORBi |
 | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., & Chapelle, J.-P. (18 February 2012). Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: Towards the end of a strange story? Clinica Chimica Acta, 413 (3-4), 527-528. doi:10.1016/j.cca.2011.11.014 Peer Reviewed verified by ORBi |
 | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034 Peer Reviewed verified by ORBi |
 | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & Souberbielle, J.-C. (2012). Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clinical Biochemistry, 45, 505-508. doi:10.1016/j.clinbiochem.2012.01.021 Peer Reviewed verified by ORBi |
| DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact » [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland. |
 | CAVALIER, E., DELANAYE, P., VRANKEN, L., BEKAERT, A.-C., CARLISI, I., Chapelle, J.-P., & SOUBERBIELLE, J.-C. (2012). Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology Dialysis Transplantation, 27, 1950-56. doi:10.1093/ndt/gfr535 Peer Reviewed verified by ORBi |
 | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190. Peer Reviewed verified by ORBi |
 | CAVALIER, E., DELANAYE, P., VRANKEN, L., CARLISI, I., BEKAERT, A.-C., Chapelle, J.-P., & Souberbielle, J.-C. (October 2011). Impact of the use of the Manufacture's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Clinical Chemistry, 57 (S10), 191. Peer Reviewed verified by ORBi |
| CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States. |
| CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States. |
| CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States. |
 | CAVALIER, E., CARLISI, I., & DELANAYE, P. (May 2011). Human anti-animal antibodies: even today, it is still a problem in routine practice: illustration with 4 clinical cases. Clinical Chemistry and Laboratory Medicine, 49 (s1), 409. Peer Reviewed verified by ORBi |
 | Cavalier, E., Huberty, V., Carlisi, I., Chapelle, J.-P., Vroonen, L., & Beckers, A. (18 March 2011). Human anti-animal antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay: about one case. Clinica Chimica Acta, 412 (7-8), 668-669. doi:10.1016/j.cca.2010.12.035 Peer Reviewed verified by ORBi |
 | CAVALIER, E., WALLACE, A. M., CARLISI, I., CHAPELLE, J.-P., DELANAYE, P., & SOUBERBIELLE, J.-C. (2011). Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clinical Chemistry and Laboratory Medicine, 49 (3), 555-8. doi:10.1515/CCLM.2011.072 Peer Reviewed verified by ORBi |
 | Cavalier, E., Bekaert, A.-C., Carlisi, I., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2011). Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine, 49 (2), 339-341. doi:10.1515/CCLM.2011.044 Peer Reviewed verified by ORBi |
 | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036 Peer Reviewed verified by ORBi |
 | CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418. Peer Reviewed verified by ORBi |
 | Cavalier, E., Carlisi, I., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (2010). Dosage de la 25-OH vitamine D: attention aux erreurs analytiques! Congrès de la Société Française d'Endocrinologie. Peer reviewed |
 | Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96. Peer Reviewed verified by ORBi |
 | Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56. Peer Reviewed verified by ORBi |
 | Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188. Peer Reviewed verified by ORBi |
 | Cavalier, E., Rozet, E., Gadisseur, R., Carlisi, I., Monge, M., Chapelle, J.-P., Hubert, P., Souberbielle, J.-C., & Delanaye, P. (2010). Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis International, 21, 1047-1051. doi:10.1007/s00198-009-1052-5 Peer Reviewed verified by ORBi |
| Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019 Peer Reviewed verified by ORBi |
| Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032). Peer Reviewed verified by ORBi |
| Cavalier, E., Carlisi, I., Chapelle, J.-P., & Rozet, E. (June 2009). VALIDATION AND ACCURACY PROFILES OF THE LIAISON BAP_OSTASE (DIASORIN), A NEW METHOD FOR THE DETERMINATION OF BONE ALKALINE PHOSPHATASE. Clinical Chemistry and Laboratory Medicine, 47 (51). Peer Reviewed verified by ORBi |
| Cavalier, E., Delanaye, P., Bekaert, A.-C., Carlisi, I., & Chapelle, J.-P. (June 2009). Establishment of a reference range for the Bone Alkaline Phosphatase (BAP) with Diasorin Liaison in a biologically well-designed population. Clinical Chemistry, 55 (S6), 178. Peer Reviewed verified by ORBi |
| Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1 Peer Reviewed verified by ORBi |
 | Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015 Peer Reviewed verified by ORBi |
| Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191. Peer Reviewed verified by ORBi |
 | Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91. Peer reviewed |
 | Cavalier, E., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (2008). Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid [letter to the editor]. Clinical Chemistry, 54 (5), 929-30. doi:10.1373/clinchem.2007.100636 Peer Reviewed verified by ORBi |
| Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192. Peer Reviewed verified by ORBi |
| Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45. Peer Reviewed verified by ORBi |
| Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45. Peer Reviewed verified by ORBi |
Cavalier, E., Delanaye, P., Carlisi, I., Rogister, C., Mourad, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). High prevalence of vitamin D deficiency in pregnant women and new mothers in the area of Liège, Belgium [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands. |
Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Stability of intact parathormone in hemodialyzed patients: a pragmatic study on Roche Elecsys assay [Poster presentation]. Réunion de la Société Belge de Néphrologie, Brussels, Belgium. |
| Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée. Peer reviewed |
| Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée. Peer reviewed |
Cavalier, E., Carlisi, I., Delanaye, P., Pazzaglia, G., Krzesinski, J.-M., & Chapelle, J.-P. (October 2004). Comparaison of liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients [Poster presentation]. 21ème Colloque CORATA, Paris, France. |